Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
58 studies found for:    (HIV infections) [CONDITION] AND vaccine [TREATMENT] | Open Studies
Show Display Options
Rank Status Study
21 Recruiting HPV (Human Papilloma Virus) Vaccination After Treatment of Anal Intraepithelial Neoplasia (AIN)
Conditions: AIN;   HIV
Intervention: Biological: Gardasil
22 Not yet recruiting REMUNE HIV/AIDS Vaccine Phase II Pediatric Safety & Efficacy Clinical Study
Condition: HIV/AIDS
Intervention: Biological: REMUNE
23 Recruiting Trial of the Safety and Immunogenicity of an Oral, Replicating Ad26 Vectored HIV-1 Vaccine
Condition: HIV
Interventions: Biological: rcAd26.MOS1.HIV-Env 1x10^8 vp;   Biological: rcAd26.MOS1.HIV-Env 1x10^9 vp;   Biological: rcAd26.MOS1.HIV-Env 1x10^10 vp;   Biological: rcAd26.MOS1.HIV-Env 1x10^11 vp
24 Unknown  Safety and Immunogenicity of MVA85A Prime and Bacille Calmette-Guerin Boost Vaccination
Conditions: Tuberculosis;   HIV
Interventions: Biological: MVA85A;   Biological: Candin;   Biological: BCG Vaccine SSI
25 Not yet recruiting Safety and Immunological Response of a Boosting Dose of MVA-B in Healthy Volunteers After 4 Years of Receiving MVA-B
Condition: HIV Infections
Intervention: Biological: Experimental
26 Recruiting Immunogenicity of Three HIV GTU® MultiHIV DNA Immunisations Administered Via Intramuscular, Intradermal and Transcutaneous Routes
Condition: HIV
Intervention: Biological: GTU®-multiHIV B clade
27 Unknown  Efficiency of the Hepatitis B Sci-B-Vac Vaccine in HIV Positive Patients
Condition: HIV
Intervention: Biological: Sci-B-Vac
28 Recruiting Mechanisms of Impaired HIV-associated B Cell and Pneumococcal Vaccine Responses
Conditions: HIV;   Pneumococcal Infections;   Pneumococcal Vaccines
Interventions: Biological: PCV-13;   Biological: PPSV-23
29 Recruiting A Study to Assess the Safety of HIV and Hep C Vaccine Candidates When Given Separately or in Combination
Conditions: Hepatitis C Infection;   HIV Infection
Interventions: Biological: AdCh3NSmut1;   Biological: MVA-NSmut;   Biological: ChAdV63.HIVconsv;   Biological: MVA.HIVconsv
30 Recruiting Investigating Immunisation Strategies of DNA, MVA and CN54rgp140 Adjuvanted With GLA-AF to Maximise Antibody Responses
Condition: HIV
Interventions: Biological: DNA;   Biological: MVA-C;   Biological: CN54rgp140;   Biological: GLA-AF
31 Not yet recruiting Comparative Efficacy of an Intensified Re-vaccination Scheme for Hepatitis B Virus Infection Among Patients Infected With HIV .
Conditions: Hepatitis B;   HIV
Intervention: Biological: Recombinant Hepatitis B Virus Vaccine
32 Unknown  Hepatitis Vaccination in HIV Infection: Role of Adjuvant Interleukin-2
Conditions: HIV Infections;   Hepatitis A;   Hepatitis B
Interventions: Biological: Twinrix;   Biological: interleukin-2
33 Recruiting Lipopeptide Immunisation With GTU-multiHIV Trial
Condition: HIV-1 Infection
Interventions: Biological: Placebos of GTU-multiHIV B and LIPO-5 vaccines;   Biological: GTU-multHIV B vaccine and LIPO-5 vaccine
34 Recruiting Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males
Conditions: Anal Cancer;   Nonneoplastic Condition;   Penile Cancer;   Precancerous Condition
Interventions: Biological: quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine;   Other: laboratory biomarker analysis
35 Recruiting Study of Safety and Immunogenicity of HIV Vaccines in Healthy Volunteers
Conditions: Healthy Volunteer;   HIV Vaccine
Interventions: Biological: Ad4-mgag;   Biological: Ad4-EnvC150
36 Not yet recruiting Evaluating the Safety and Immune Response to Three Different DNA HIV Vaccines Administered With a MVA-CMDR Boost Vaccine in Healthy, HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: DNA Nat-B env;   Biological: DNA CON-S env;   Biological: DNA Mosaic env;   Biological: MVA-CMDR;   Biological: Placebo for DNA Nat-B env;   Biological: Placebo for DNA CON-S env;   Biological: Placebo for DNA Mosaic env;   Biological: Placebo for MVA-CMDR
37 Recruiting Safety and Immunogenicity Study of a DNA Vaccine Combined With Protein Vaccine Against HIV/AIDS
Condition: HIV/AIDS
Interventions: Biological: DNA;   Biological: AIDSVAX B/E
38 Not yet recruiting Research In Viral Eradication of HIV Reservoirs
Condition: HIV
Interventions: Drug: Combination Antiretroviral Therapy (cART);   Drug: Raltegravir;   Drug: Vorinostat;   Biological: ChAdV63.HIVconsv (ChAd);   Biological: MVA.HIVconsv (MVA)
39 Unknown  Human Papillomavirus Infection and Knowledge and Attitudes About HPV Vaccines Among Men Who Have Sex With Men (MSM)
Conditions: HPV Infection;   HIV Infection;   Syphilis
Intervention:
40 Recruiting Safety, Tolerability, and Immunogenicity Study of Homologous Ad26 Mosaic Vector Vaccine Regimens or Heterologous Ad26 Mosaic and MVA Mosaic Vector Vaccine Regimens With Glycoprotein 140 (gp140) for Human Immunodeficiency Virus (HIV) Prevention
Condition: Healthy
Interventions: Biological: Ad26.Mos.HIV;   Biological: MVA-Mosaic;   Biological: gp140 DP Low-dose;   Biological: gp140 DP High-dose;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-58) Show next page of results    Last Page
Indicates status has not been verified in more than two years